E
Elisa F Long
Researcher at University of California, Los Angeles
Publications - 40
Citations - 1823
Elisa F Long is an academic researcher from University of California, Los Angeles. The author has contributed to research in topics: Cost effectiveness & Population. The author has an hindex of 20, co-authored 39 publications receiving 1544 citations. Previous affiliations of Elisa F Long include Stanford University & Yale University.
Papers
More filters
Journal ArticleDOI
HIV treatment as prevention: Systematic comparison of mathematical models of the potential impact of antiretroviral therapy on HIV incidence in South Africa
Jeffrey W. Eaton,Leigh F. Johnson,Joshua A. Salomon,Till Bärnighausen,Till Bärnighausen,Eran Bendavid,Anna Bershteyn,David E. Bloom,Valentina Cambiano,Christophe Fraser,Jan A. C. Hontelez,Salal Humair,Salal Humair,Daniel J. Klein,Elisa F Long,Andrew N. Phillips,Carel Pretorius,John Stover,Edward Allen Wenger,Brian G. Williams,Timothy B. Hallett +20 more
TL;DR: In this article, the authors compared the predictions of several mathematical models simulating the same ART intervention programmes to determine the extent to which models agree about the epidemiological impact of expanded ART.
Maternal and neonatal outcomes of elective induction of labor.
Aaron B. Caughey,Vandana Sundaram,Anjali J Kaimal,Yvonne W. Cheng,Allison Gienger,Sarah E Little,Jason F Lee,Luchin Wong,Brian L Shaffer,Susan H Tran,Amy Padula,Kathryn M. McDonald,Elisa F Long,Douglas K Owens,Dena M. Bravata +14 more
TL;DR: Overall, expectant management of pregnancy was associated with an approximately 22 percent higher odds of cesarean delivery than elective induction of labor, and the evidence was rated as moderate because of the size and number of studies and consistency of the findings.
Journal ArticleDOI
The Cost-Effectiveness and Population Outcomes of Expanded HIV Screening and Antiretroviral Treatment in the United States
TL;DR: Expanding HIV screening and treatment simultaneously offers the greatest health benefit and is cost-effective, however, even substantial expansion of HIV screenings and treatment programs is not sufficient to markedly reduce the U.S. HIV epidemic without substantial reductions in risk behavior.
Journal ArticleDOI
Nursing home staff networks and COVID-19.
TL;DR: Results suggest that eliminating staff linkages between nursing homes could reduce COVID-19 infections in nursing homes by 44 percent, and traditional federal regulatory metrics of nursing home quality are unimportant in predicting outbreaks, consistent with recent research.
Journal ArticleDOI
Comparative Survival and Cost-Effectiveness of Advanced Therapies for End-Stage Heart Failure
TL;DR: Under most scenarios, OHT prolongs life and is cost effective in eligible patients, and destination therapy-LVAD significantly improves life expectancy in OHT-ineligible patients, however, further reductions in adverse events or improved quality of life are needed to be cost effective.